Massachusetts Financial Services CO Bio Techne Corp Transaction History

Massachusetts Financial Services CO

$321 Billion
Q1 2024

A detailed history of Massachusetts Financial Services CO transactions in Bio Techne Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 2,501,542 shares of TECH stock, worth $193 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,501,542

Previous 784,543 218.85%

Holding current value

$193 Million

Previous $60.5 Million 190.88%

% of portfolio

0.05%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $113 Million - $132 Million	1,716,999 Added 218.85%	2,501,542 $176 Million
Q4 2023 Feb 08, 2024	BUY	$52.83 - $78.22 $38.7 Million - $57.2 Million	731,869 Added 1389.43%	784,543 $60.5 Million
Q3 2023 Nov 08, 2023	SELL	$67.52 - $89.42 $8,912 - $11,803	-132 Reduced 0.25%	52,674 $3.59 Million
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $25.5 Million - $29.7 Million	-345,134 Reduced 86.73%	52,806 $4.31 Million
Q1 2023 May 10, 2023	SELL	$71.62 - $86.62 $53.4 Million - $64.6 Million	-746,091 Reduced 65.22%	397,940 $29.5 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $68.2 Million - $298 Million	845,310 Added 282.98%	1,144,031 $94.8 Million
Q3 2022 Nov 09, 2022	SELL	$282.54 - $391.85 $49.8 Million - $69 Million	-176,131 Reduced 37.09%	298,721 $84.8 Million
Q2 2022 Aug 09, 2022	SELL	$322.67 - $449.65 $23 Million - $32.1 Million	-71,323 Reduced 13.06%	474,852 $165 Million
Q1 2022 May 11, 2022	SELL	$353.85 - $487.79 $64.4 Million - $88.7 Million	-181,860 Reduced 24.98%	546,175 $237 Million
Q4 2021 Feb 10, 2022	SELL	$456.15 - $525.06 $33 Million - $38 Million	-72,394 Reduced 9.04%	728,035 $377 Million
Q3 2021 Nov 10, 2021	SELL	$444.87 - $538.88 $3.19 Million - $3.86 Million	-7,165 Reduced 0.89%	800,429 $388 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $37.7 Million - $43.8 Million	-97,214 Reduced 10.74%	807,594 $364 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $4.98 Million - $6.51 Million	-15,839 Reduced 1.72%	904,808 $346 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $9.22 Million - $12 Million	37,341 Added 4.23%	920,647 $292 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $6.63 Million - $8.08 Million	28,554 Added 3.34%	883,306 $219 Million
Q2 2020 Aug 11, 2020	SELL	$185.43 - $279.56 $6.56 Million - $9.89 Million	-35,372 Reduced 3.97%	854,752 $226 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $13.7 Million - $18.9 Million	85,222 Added 10.59%	890,124 $169 Million
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $27.8 Million - $32.5 Million	-146,399 Reduced 15.39%	804,902 $177 Million
Q3 2019 Nov 05, 2019	BUY	$183.56 - $216.72 $5.82 Million - $6.87 Million	31,700 Added 3.45%	951,301 $186 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $12.1 Million - $13.8 Million	63,976 Added 7.48%	919,601 $192 Million
Q1 2019 May 13, 2019	BUY	$136.09 - $200.44 $7.08 Million - $10.4 Million	51,992 Added 6.47%	855,625 $170 Million
Q4 2018 Feb 08, 2019	BUY	$132.75 - $203.8 $16.7 Million - $25.6 Million	125,665 Added 18.54%	803,633 $116 Million
Q3 2018 Oct 25, 2018	BUY	$147.44 - $204.11 $11.8 Million - $16.3 Million	79,963 Added 13.37%	677,968 $138 Million
Q2 2018 Jul 30, 2018	BUY	$144.9 - $165.58 $19.5 Million - $22.3 Million	134,771 Added 29.09%	598,005 $88.5 Million
Q1 2018 May 04, 2018	BUY	$131.46 - $151.04 $49.4 Million - $56.7 Million	375,629 Added 428.78%	463,234 $70 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $139,830 - $155,501	1,154 Added 1.33%	87,605 $11.3 Million
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $1.46 Million - $1.59 Million	-12,816 Reduced 12.91%	86,451 $10.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	99,267	99,267 $11.7 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Bio Techne Corp Transaction History